BICX BioCorRx Inc.
Services-Specialty Outpatient Facilities, NEC · OTC · SEC CIK 1443863 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-78.9%
TTM net income YoY51.3%
TTM EPS YoY52.0%
Revenue 3-yr CAGR-10.2%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-3,921.4%
Net margin-1,837.6%
FCF margin—
EBITDA margin-4,007.3%
Returns
ROE—
ROA-43.8%
ROIC (approx.)—
Asset turnover0.02x
Leverage & solvency
Liabilities / assets826.2%
Debt / equity—
Current ratio0.06x
Interest coverage-30.03x
Cash quality & payout
Operating cash flow / net income0.93x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $797,244 | $7,665 |
| Cost of revenue | — | $1,667 |
| Gross profit | — | $5,998 |
| R&D expense | $1.77M | $1.48M |
| SG&A expense | $3.79M | $3.61M |
| Operating income | -$4.83M | -$5.12M |
| Interest expense | $223,850 | $776,780 |
| Pretax income | -$3.51M | -$5.21M |
| Income tax | $0 | $0 |
| Net income | -$3.44M | -$5.11M |
| EBITDA | -$4.79M | -$5.09M |
| EPS (diluted) | -0.19 | -0.49 |
| Weighted avg. shares (diluted) | 18.49M | 10.46M |
| Banking | ||
| Noninterest income | — | $105,978 |
| Balance sheet | ||
| Cash & equivalents | $139,360 | $88,033 |
| Receivables | $253,459 | $0 |
| Inventory | $143,425 | $0 |
| Current assets | $814,468 | $117,996 |
| PP&E, net | $4,062 | $18,977 |
| Goodwill | $563,158 | $0 |
| Intangibles | $564,460 | $7,848 |
| Total assets | $2.15M | $385,941 |
| Current liabilities | $8.31M | $8.21M |
| Short-term debt | $0 | — |
| Total liabilities | $13.67M | $12.74M |
| Shareholders' equity | -$11.22M | -$12.12M |
| Shares outstanding | 24.49M | 13.30M |
| Cash flow statement | ||
| Operating cash flow | -$2.30M | -$1.10M |
| Financing cash flow | $2.35M | $1.12M |
| Depreciation & amortization | $44,003 | $33,145 |
| Stock-based compensation | $592,604 | $1.22M |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.